Comparing Arexvy vs Synagis
| Arexvy (rsv vaccine pref3, recombinant) | Synagis (palivizumab) |
|
|---|
| Arexvy (rsv vaccine pref3, recombinant) | Synagis (palivizumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for RSV Vaccination and Immunization, RSV. Arexvy may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for RSV Vaccination and Immunization, RSV. Synagis may also be used for purposes not listed in this medication guide. |
Related suggestions RSV Vaccination and Immunization
|
|||||||||||||||
| More about Arexvy (rsv vaccine pref3, recombinant) | More about Synagis (palivizumab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Arexvy side effects |
View all Synagis side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Arexvy prices |
View all Synagis prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
N/A |
432 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 301 drugs are known to interact with Arexvy:
|
A total of 4 drugs are known to interact with Synagis:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
June 19, 1998 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Abrysvo
Abrysvo is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Beyfortus
Beyfortus is used to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in ...
mRESVIA
mRESVIA is a vaccine used to immunize adults aged 60 years and older against lower respiratory ...
Palivizumab
Palivizumab is used for RSV, RSV Vaccination and Immunization
Nirsevimab
Nirsevimab information from Drugs.com, includes Nirsevimab side effects, interactions and indications.
Rsv vaccine, pref a-pref b, recombinant
Respiratory Syncytial Virus (RSV) vaccines (Abrysvo, Arexvy, mResvia) are used to help reduce the ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.